Skip to main content
. 2013 Jul 24;8(7):e69020. doi: 10.1371/journal.pone.0069020

Table 1. Overview of studies and nanomaterials.

Study Exposure way Particles Deposited dose (µg) Declared particle size Agglomerated size in inhalation aerosol or instillation suspension Reference
1 Intratracheal NanoCB 18, 54, 162 14 nm 200 nm? [20]
instillation NanoTiO2 18, 54, 162 17 nm 100 nm?
MWCNT 18, 54, 162 40–50 nm×1–4 µm ND§
SWCNT1 18, 54, 162 1.1 nm×0.5–100µm ND§
SWCNT2 18, 54, 162 0.8–1.7nm×≤1 µm ND§
2** Intratracheal MWCNT 18, 54, 128 40–50 nm×1– 4 µm ND§
instillation
3 Inhalation NanoCB 75 14 nm 65 nm [32]
DEP 19* 1.62 µm 215 nm
4 Inhalation NanoTiO2 73 17 nm 97 nm [19]
5 Inhalation NanoCB 287 14 nm 310 nm (bimodal; 290 and 1500 nm) [22]
6 Intratracheal Boiler dust 216 ND§ ND§ [31]
instillation Storage dust 216 ND§ ND§
*

Based on a deposition fraction similar to NanoTiO2, Mean diameter (number distribution) from National Institute of Standards and Technology, Certificate of Analysis, Standard Reference Material® 2975, Geometric mean, § Not detetermined, ? Hydrodynamic size, ** Study 2 was an additional experiment performed to obtain plasma from MWCNT instilled mice and control animals.